Michael Hennig, Prof., PhD
Posted on May 1st, 2017
After his PhD at the EMBL Hamburg and a postdoc at the Biozentrum of the University of Basel Michael Hennig looks back to 20 years of drug discovery expertise in structural biology and research management at F. Hoffmann – La Roche AG Basel. Helped deliver Tamiflu, Fortovase, Xenical, Carmegliptin, Aleglitazar and is author of more than 70 articles and 8 patents. He holds a professorship position for structural biology at the University of Basel.
Rafael Abela, PhD
Posted on April 1st, 2017
Scientific leader of the Swiss Light Source (SLS) project and project leader for photonics and research of the Swiss Free Electron Laser (SwissFEL) at the Paul Scherrer Institute PSI. More than 80 peer-reviewed publications
Pascale Bruderer Wyss, M.A.
Posted on November 27th, 2016
After studying Politics and Law at University of Zürich, Växjö (Sweden) and Havard University Boston (USA), Pascale Bruderer Wyss began her career at UBS in finance roles and at Microsoft Switzerland as manager of social projects. She co-founded the company ’’machs! GmbH“ focusing on communication, personnel and financial consultancy. She then had roles with increasing political responsibility from city council Baden 1997, council of the canton Aargau (election 2001), 2002 national council in Bern, 2009 president of the national council of Switzerland. Other appointments include the secretariat of the Swiss cancer foundation, the membership of the advisory Board of the Swiss Economic Forum and of the development location PARK INNOVAARE. Pascale Bruderer Wyss was elected „politician of the year” in 2010.
Posted on September 27th, 2016
Physics studies at the ETH Zürich, Head of staff, PSI 1998-2012, head of PSI proton therapy development program 2000-2012, acting director of PSI 2007-2008
Christof Gerber, M.D.
Posted on September 15th, 2016
He started his career as an economist in the banking industry and completed post-graduate medical training in anesthesiology and emergency medicine. In 2017 he co-founded a medical device start-up company where he serves as the CEO. He has been a Board Member at leadXpro since 2016.
Andreas Insam, Dr. rer. soc. oec.
Posted on June 16th, 2016
Dr. Insam holds the qualification Dr. rer. soc. oec. from the University of Innsbruck. He has been CEO of BENDURA BANK AG since it was founded in 1998. He was previously a long-standing member of the Board of Managers of LGT Bank in Liechtenstein (Frankfurt) GmbH, responsible for the Institutional Sales division. After he obtained his doctorate in Business Administration, he served as Research Assistant at the University of Innsbruck’s Institute of Mathematics and Statistics, and later became Assistant to the Executive Board of LGT Bank in Liechtenstein. Andreas Insam has been a lecturer and examiner at the University of Liechtenstein for many years.